RxDoctor Payments Data

Sarah Welch

Family · Murfreesboro, TNNPI 1326178476

Payments from drug & device makers

$4,627in general payments, 2019–2025

Across 189 payments — averaging $24.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$739
  • AbbVie$663
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$543
  • Vanda Pharmaceuticals Inc.$452
  • Axsome Therapeutics, Inc.$438
  • Alkermes, Inc.$394
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$4,46697%
  • Education$1613%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,627 in reported general payments places this provider in the 90th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
CaplytaLumateperone Tosylate16$29,001
VraylarCariprazine Hcl16$22,695
TrintellixVortioxetine Hydrobromide12$5,418
Quetiapine Fumarate60$1,020
Bupropion XlBupropion Hcl30$834
Duloxetine Hcl29$774
Buspirone Hcl49$701
Oxcarbazepine16$666
Hydroxyzine Hcl33$576
Citalopram HbrCitalopram Hydrobromide36$429
Albuterol Sulfate HfaAlbuterol Sulfate16$416
Aripiprazole14$365
Venlafaxine Hcl ErVenlafaxine Hcl11$324
Mirtazapine13$265
Trazodone Hcl38$263

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$543$29,00116 claims
AbbVieVraylar$663$22,69516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,706 family providers in Tennessee.

Other family in Murfreesboro

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →